Brain metastasis-initiating cells: Survival of the fittest

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 9117-9133

  Singh, Mohini ^a,b   Manoranjan, Branavan ^a,b   Mahendram, Sujeivan ^a   McFarlane, Nicole ^a   Venugopal, Chitra ^a   Singh, Sheila K ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Brain metastasis; Brain metastasis initiating cell; Brain tumor; Brain tumor initiating cell; Cancer stem cell

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID CARRIER; CATENIN; CD133 ANTIGEN; CD15 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; GELATINASE A; HERMES ANTIGEN; JAGGED1; KRUPPEL LIKE FACTOR 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SIALYLTRANSFERASE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN;

APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN METASTASIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; CELL RENEWAL; CIRCULATING TUMOR CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRAVASATION; FLOW CYTOMETRY; HUMAN; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STEM CELL NICHE; TUMOR BLOOD FLOW; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN TUMOR; BREAST TUMOR; FEMALE; LUNG TUMOR; METABOLISM; PATHOLOGY; SECONDARY; SKIN TUMOR; TUMOR EMBOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; SKIN NEOPLASMS;

EID: 84901349980     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15059117     Document Type: Review

References (86)

1. Langley, R.R.; Fidler, I.J. The biology of brain metastasis. Clin. Chem. 2013, 59, 180-189.
2. Rahmathulla, G.; Toms, S.A.; Weil, R.J. The molecular biology of brain metastasis. J. Oncol. 2012, 2012, 723541.
3. Sjobakk, T.E.; Vettukattil, R.; Gulati, M.; Gulati, S.; Lundgren, S.; Gribbestad, I.S.; Torp, S.H.; Bathen, T.F. Metabolic profiles of brain metastases. Int. J. Mol. Sci. 2013, 14, 2104-2118.
4. Kress, M.A.; Oermann, E.; Ewend, M.G.; Hoffman, R.B.; Chaudhry, H.; Collins, B. Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: Progression of extracranial disease correlates with distant intracranial failure. Radiat. Oncol. 2013, 8, 64.
5. Palmieri, D. An introduction to brain metastasis. In Central Nervous System Metastasis, the Biological Basis and Clinical Considerations; Palmieri, D., Ed.; Springer: Dordrecht, The Netherlands, 2012; pp. 1-13.
6. Patchell, R.A. The management of brain metastases. Cancer Treat. Rev. 2003, 29, 533-540.
7. Soffietti, R.; Ruda, R.; Mutani, R. Management of brain metastases. J. Neurol. 2002, 249, 1357-1369.
8. Delattre, J.Y.; Krol, G.; Thaler, H.T.; Posner, J.B. Distribution of brain metastases. Arch. Neurol. 1988, 45, 741-744.
9. Berghoff, A.S.; Rajky, O.; Winkler, F.; Bartsch, R.; Furtner, J.; Hainfellner, J.A.; Goodman, S.L.; Weller, M.; Schittenhelm, J.; Preusser, M. Invasion patterns in brain metastases of solid cancers. Neuro Oncol. 2013, 15, 1664-1672.
10. Weiss, L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin. Exp. Metastasis 1992, 10, 191-199.
11. Chiang, A.C.; Massague, J. Molecular basis of metastasis. N. Engl. J. Med. 2008, 359, 2814-2823.
12. Cameron, M.D.; Schmidt, E.E.; Kerkvliet, N.; Nadkarni, K.V.; Morris, V.L.; Groom, A.C.; Chambers, A.F.; MacDonald, I.C. Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 2000, 60, 2541-2546.
13. Luzzi, K.J.; MacDonald, I.C.; Schmidt, E.E.; Kerkvliet, N.; Morris, V.L.; Chambers, A.F.; Groom, A.C. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 1998, 153, 865-873.
14. Fidler, I.J. Cancer metastasis. Br. Med. Bull. 1991, 47, 157-177.
15. Steeg, P.S. Tumor metastasis: Mechanistic insights and clinical challenges. Nat. Med. 2006, 12, 895-904.
16. Beasley, K.D.; Toms, S.A. The molecular pathobiology of metastasis to the brain: A review. Neurosurg. Clin. N. Am. 2011, 22, 7-14.
17. Yoshimasu, T.; Sakurai, T.; Oura, S.; Hirai, I.; Tanino, H.; Kokawa, Y.; Naito, Y.; Okamura, Y.; Ota, I.; Tani, N., et al. Increased expression of integrin α3β1 in highly brain metastatic subclone of a human non-small cell lung cancer cell line. Cancer Sci. 2004, 95, 142-148.
18. Gavrilovic, I.T.; Posner, J.B. Brain metastases: Epidemiology and pathophysiology. J. Neuro Oncol. 2005, 75, 5-14.
19. Quail, D.F.; Joyce, J.A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 2013, 19, 1423-1437.
20. Nieswandt, B.; Hafner, M.; Echtenacher, B.; Mannel, D.N. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999, 59, 1295-1300.
21. Grossmann, J. Molecular mechanisms of detachment-induced apoptosis-Anoikis. Apoptosis 2002, 7, 247-260.
22. Gay, L.J.; Felding-Habermann, B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 2011, 11, 123-134.
23. Kienast, Y.; von Baumgarten, L.; Fuhrmann, M.; Klinkert, W.E.; Goldbrunner, R.; Herms, J.; Winkler, F. Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 2010, 16, 116-122.
24. Ramakrishna, R.; Rostomily, R. Seed, soil, and beyond: The basic biology of brain metastasis. Surg. Neurol. Int. 2013, 4, S256-S264.
25. Chambers, A.F.; Groom, A.C.; MacDonald, I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2, 563-572.
26. Valiente, M.; Obenauf, A.C.; Jin, X.; Chen, Q.; Zhang, X.H.; Lee, D.J.; Chaft, J.E.; Kris, M.G.; Huse, J.T.; Brogi, E., et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014, 156, 1002-1016.
27. Fayard, B.; Bianchi, F.; Dey, J.; Moreno, E.; Djaffer, S.; Hynes, N.E.; Monard, D. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res. 2009, 69, 5690-5698.
28. Shellenberger, T.D.; Mazumdar, A.; Henderson, Y.; Briggs, K.; Wang, M.; Chattopadhyay, C.; Jayakumar, A.; Frederick, M.; Clayman, G.L. Headpin: A serpin with endogenous and exogenous suppression of angiogenesis. Cancer Res. 2005, 65, 11501-11509.
29. Yin, S.; Lockett, J.; Meng, Y.; Biliran, H., Jr.; Blouse, G.E.; Li, X.; Reddy, N.; Zhao, Z.; Lin, X.; Anagli, J., et al. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res. 2006, 66, 4173-4181.
30. Xiao, G.; Liu, Y.E.; Gentz, R.; Sang, Q.A.; Ni, J.; Goldberg, I.D.; Shi, Y.E. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc. Natl. Acad. Sci. USA 1999, 96, 3700-3705.
31. Vanharanta, S.; Massague, J. Origins of metastatic traits. Cancer Cell 2013, 24, 410-421.
32. Fidler, I.J.; Schackert, G.; Zhang, R.D.; Radinsky, R.; Fujimaki, T. The biology of melanoma brain metastasis. Cancer Metastasis Rev. 1999, 18, 387-400.
33. Stephen Paget's paper reproduced from The Lancet, 1889. Cancer Metastasis Rev. 1989, 8, 98-101.
34. Fidler, I.J. The pathogenesis of cancer metastasis: The "seed and soil" hypothesis revisited. Nat. Rev. Cancer 2003, 3, 453-458.
35. James Ewing, A.M. Neoplastic diseases: A treatise on tumours. Br. J. Surg. 1928, 16, 174-175.
36. Weiss, L. Metastasis of cancer: A conceptual history from antiquity to the 1990s. Cancer Metastasis Rev. 2000, 19, 193-383.
37. Sugarbaker, E.V. Cancer metastasis: A product of tumor-host interactions. Curr. Probl. Cancer 1979, 3, 1-59.
38. Thiery, J.P.; Acloque, H.; Huang, R.Y.; Nieto, M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139, 871-890.
39. Lillie, F.R. The Development of the Chick: An Introduction to Embryology, 2nd ed.; Henry Holt: New York, NY, USA, 1936.
40. Scheel, C.; Weinberg, R.A. Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links. Semin. Cancer Biol. 2012, 22, 396-403.
41. Kong, D.; Li, Y.; Wang, Z.; Sarkar, F.H. Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: Are they cousins or twins? Cancers 2011, 3, 716-729.
42. Huber, M.A.; Kraut, N.; Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005, 17, 548-558.
43. Oskarsson, T.; Batlle, E.; Massague, J. Metastatic stem cells: Sources, niches, and vital pathways. Cell Stem Cell 2014, 14, 306-321.
44. Brabletz, T.; Jung, A.; Reu, S.; Porzner, M.; Hlubek, F.; Kunz-Schughart, L.A.; Knuechel, R.; Kirchner, T. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA 2001, 98, 10356-10361.
45. Morel, A.P.; Lievre, M.; Thomas, C.; Hinkal, G.; Ansieau, S.; Puisieux, A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3, e2888.
46. Gupta, G.P.; Massague, J. Cancer metastasis: Building a framework. Cell 2006, 127, 679-695.
47. Clarke, M.F.; Dick, J.E.; Dirks, P.B.; Eaves, C.J.; Jamieson, C.H.M.; Jones, D.L.; Visvader, J.; Weissman, I.L.; Wahl, G.M. Cancer stem cells-Perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006, 66, 9339-9344.
48. Bonnet, D.; Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3, 730-737.
49. Ailles, L.E.; Weissman, I.L. Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 2007, 18, 460-466.
50. Singh, S.K.; Hawkins, C.; Clarke, I.D.; Squire, J.A.; Bayani, J.; Hide, T.; Henkelman, R.M.; Cusimano, M.D.; Dirks, P.B. Identification of human brain tumour initiating cells. Nature 2004, 432, 396-401.
51. Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 3983-3988
52. O'Brien, C.A.; Pollett, A.; Gallinger, S.; Dick, J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445, 106-110.
53. Patrawala, L.; Calhoun, T.; Schneider-Broussard, R.; Li, H.; Bhatia, B.; Tang, S.; Reilly, J.G.; Chandra, D.; Zhou, J.; Claypool, K., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25, 1696-1708.
54. Collins, A.T.; Berry, P.A.; Hyde, C.; Stower, M.J.; Maitland, N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65, 10946-10951.
55. Magee, J.A.; Piskounova, E.; Morrison, S.J. Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer Cell 2012, 21, 283-296.
56. Goodison, S.; Kawai, K.; Hihara, J.; Jiang, P.; Yang, M.; Urquidi, V.; Hoffman, R.M.; Tarin, D. Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin. Cancer Res. 2003, 9, 3808-3814.
57. Celia-Terrassa, T.; Meca-Cortes, O.; Mateo, F.; de Paz, A.M.; Rubio, N.; Arnal-Estape, A.; Ell, B.J.; Bermudo, R.; Diaz, A.; Guerra-Rebollo, M., et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J. Clin. Investig. 2012, 122, 1849-1868.
58. Nolte, S.M.; Venugopal, C.; McFarlane, N.; Morozova, O.; Hallett, R.M.; O'Farrell, E.; Manoranjan, B.; Murty, N.K.; Klurfan, P.; Kachur, E., et al. A cancer stem cell model for studying brain metastases from primary lung cancer. J. Natl. Cancer Inst. 2013, 105, 551-562.
59. Todorutiu, C.; Risca, R. Experimental studies on factors influencing the widespread organ distribution of Walker 256 tumour metastases. Morphol. Embryol. 1977, 23, 141-149.
60. Bos, P.D.; Nguyen, D.X.; Massague, J. Modeling metastasis in the mouse. Curr. Opin. Pharmacol. 2010, 10, 571-577.
61. Khanna, C.; Hunter, K. Modeling metastasis in vivo. Carcinogenesis 2005, 26, 513-523.
62. Cranmer, L.D.; Trevor, K.T.; Bandlamuri, S.; Hersh, E.M. Rodent models of brain metastasis in melanoma. Melanoma Res. 2005, 15, 325-356.
63. Fidler, I.J. Selection of successive tumour lines for metastasis. Nature 1973, 242, 148-149.
64. Zhang, Z.; Hatori, T.; Nonaka, H. An experimental model of brain metastasis of lung carcinoma. Neuropathology 2008, 28, 24-28.
65. Munoz, D.M.; Guha, A. Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas. Oncotarget 2011, 2, 590-598.
66. Mathieu, A.; Remmelink, M.; D'Haene, N.; Penant, S.; Gaussin, J.F.; van Ginckel, R.; Darro, F.; Kiss, R.; Salmon, I. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: Analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-α (GST)-α, GST-mu, and GST-pi. Cancer 2004, 101, 1908-1918.
67. Bos, P.D.; Zhang, X.H.; Nadal, C.; Shu, W.; Gomis, R.R.; Nguyen, D.X.; Minn, A.J.; van de Vijver, M.J.; Gerald, W.L.; Foekens, J.A., et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459, 1005-1009.
68. Banisadr, G.; Skrzydelski, D.; Kitabgi, P.; Rostene, W.; Parsadaniantz, S.M. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: Constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 2003, 18, 1593-1606.
69. Salmaggi, A.; Maderna, E.; Calatozzolo, C.; Gaviani, P.; Canazza, A.; Milanesi, I.; Silvani, A.; DiMeco, F.; Carbone, A.; Pollo, B. CXCL12, CXCR4 and CXCR7 expression in brain metastases. Cancer Biol. Ther. 2009, 8, 1608-1614.
70. Scala, S.; Ottaiano, A.; Ascierto, P.A.; Cavalli, M.; Simeone, E.; Giuliano, P.; Napolitano, M.; Franco, R.; Botti, G.; Castello, G. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin. Cancer Res. 2005, 11, 1835-1841.
71. Schrader, A.J.; Lechner, O.; Templin, M.; Dittmar, K.E.; Machtens, S.; Mengel, M.; Probst-Kepper, M.; Franzke, A.; Wollensak, T.; Gatzlaff, P., et al. CXCR4/CXCL12 expression and signalling in kidney cancer. Br. J. Cancer 2002, 86, 1250-1256.
72. Zhou, Y.; Larsen, P.H.; Hao, C.; Yong, V.W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem. 2002, 277, 49481-49487.
73. Hinton, C.V.; Avraham, S.; Avraham, H.K. Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Clin. Exp. Metastasis 2010, 27, 97-105.
74. Lee, B.C.; Lee, T.H.; Avraham, S.; Avraham, H.K. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1α in breast cancer cell migration through human brain microvascular endothelial cells. Mol. Cancer Res. 2004, 2, 327-338.
75. Furusato, B.; Mohamed, A.; Uhlen, M.; Rhim, J.S. CXCR4 and cancer. Pathol. Int. 2010, 60, 497-505.
76. Naor, D.; Nedvetzki, S.; Golan, I.; Melnik, L.; Faitelson, Y. CD44 in cancer. Crit. Rev. Clin. Lab. Sci. 2002, 39, 527-579.
77. Misra, S.; Heldin, P.; Hascall, V.C.; Karamanos, N.K.; Skandalis, S.S.; Markwald, R.R.; Ghatak, S. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011, 278, 1429-1443.
78. - breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res. 2006, 8, R59.
79. Seiter, S.; Arch, R.; Reber, S.; Komitowski, D.; Hofmann, M.; Ponta, H.; Herrlich, P.; Matzku, S.; Zoller, M. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med. 1993, 177, 443-455.
80. Luo, Y.; Ziebell, M.R.; Prestwich, G.D. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 2000, 1, 208-218.
81. Okuda, H.; Xing, F.; Pandey, P.R.; Sharma, S.; Watabe, M.; Pai, S.K.; Mo, Y.Y.; Iiizumi-Gairani, M.; Hirota, S.; Liu, Y., et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res. 2013, 73, 1434-1444.
82. Xing, F.; Kobayashi, A.; Okuda, H.; Watabe, M.; Pai, S.K.; Pandey, P.R.; Hirota, S.; Wilber, A.; Mo, Y.Y.; Moore, B.E., et al. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol. Med. 2013, 5, 384-396.
83. Mendes, O.; Kim, H.T.; Lungu, G.; Stoica, G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin. Exp. Metastasis 2007, 24, 341-351.
84. Nguyen, D.X.; Chiang, A.C.; Zhang, X.H.; Kim, J.Y.; Kris, M.G.; Ladanyi, M.; Gerald, W.L.; Massague, J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009, 138, 51-62.
85. Neman, J.; Termini, J.; Wilczynski, S.; Vaidehi, N.; Choy, C.; Kowolik, C.M.; Li, H.; Hambrecht, A.C.; Roberts, E.; Jandial, R. Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc. Natl. Acad. Sci. USA 2014, 111, 984-989.
86. Wu, X.; Northcott, P.A.; Dubuc, A.; Dupuy, A.J.; Shih, D.J.; Witt, H.; Croul, S.; Bouffet, E.; Fults, D.W.; Eberhart, C.G., et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 2012, 482, 529-533.